Prescribing practices in the treatment of depression among psychiatrists in Oman

References

1. 1.↵
   1. Lépine JP,
   2. Briley M.

   The increasing burden of depression. Neuropsychiatr Dis Treat 2011; 7: 3-7.

   OpenUrlPubMed
2. 2.↵
   1. López-Muñoz F,
   2. Alamo C.

   Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des 2009; 15: 1563-1586.

   OpenUrlCrossRefPubMed
3. 3.↵
   Depression: FDA-approved medications may help. U.S. Food and Drug Administration. From: www.fda.gov/ForConsumers/ConsumerUpdates/ucm095980.htm. Accessed: 12 April 2020.
4. 4.↵
   1. Taylor DM,
   2. Barnes TRE,
   3. Young AH.

   The Maudsley Prescribing Guidelines in Psychiatry, 13th Edition. John Wiley & Sons; 2018 May 14: 258-344.
5. 5.↵
   1. Zimmerman M,
   2. Posternak M,
   3. Friedman M,
   4. Attiullah N,
   5. Baymiller S,
   6. Boland R, et al.

   Which factors influence psychiatrists’ selection of antidepressants? Am J Psychiatry 2004; 161: 1285-1289.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Olfson M,
   2. Klerman GL.

   Trends in the prescription of antidepressants by office-based psychiatrists. Am J Psychiatry 1993; 150: 571-577.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.
   1. Olfson M,
   2. Marcus SC,
   3. Pincus HA,
   4. Zito JM,
   5. Thompson JW,
   6. Zarin DA.

   Antidepressant prescribing practices of outpatient psychiatrists. Arch Gen Psychiatry 1998; 55: 310-316.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Moore S,
   2. Jaime LK,
   3. Maharajh H,
   4. Ramtahal I,
   5. Reid S,
   6. Ramsewak FS, et al.

   The prescribing of psychotropic drugs in mental health services in Trinidad. Rev Panam Salud Publica 2002; 12: 207-214.

   OpenUrlPubMed
9. 9.↵
   1. Baboolal N.

   Prescribing practices in the treatment of depression: A survey among psychiatrists and other doctors providing psychiatric care in Trinidad and Tobago. The Internet Journal of Third World Medicine 2002; 1: 1-10.

   OpenUrl
10. 10.↵
    1. Petersen T,
    2. Dording C,
    3. Neault NB,
    4. Kornbluh R,
    5. Alpert JE,
    6. Nierenberg AA, et al.

    A survey of prescribing practices in the treatment of depression. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 177–187.

    OpenUrlCrossRefPubMed
11. 11.↵
    American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. From:https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf. Accessed: 12 April 2020
12. 12.↵
    1. Rosen RC,
    2. Lane RM,
    3. Menza M.

    Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999; 19: 67–85.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Goldstein BJ,
    2. Goodnick PJ.

    Selective serotonin reuptake inhibitors in the treatment of affective disorders—III. Tolerability, safety and pharmacoeconomics. J Psychopharmacol 1998; 12: S55-S87.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Montejo-González AL,
    2. Llorca G,
    3. Izquierdo JA,
    4. Ledesma A,
    5. Bousoño M,
    6. Calcedo A, et al.

    SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997; 23: 176-194.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Feiger A,
    2. Kiev A,
    3. Shrivastava RK,
    4. Wisselink PG,
    5. Wilcox CS.

    Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996; 57 Suppl 2: 53-62.

    OpenUrl
16. 16.↵
    1. Croft H,
    2. Settle E Jr.,
    3. Houser T,
    4. Batey SR,
    5. Donahue RM,
    6. Ascher JA.

    A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 1999; 21: 643-658.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Kavoussi RJ,
    2. Segraves RT,
    3. Hughes AR,
    4. Ascher JA,
    5. Johnston JA.

    Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. J Clin Psychiatry 1997; 58: 532-537.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Fava M.

    Weight gain and antidepressants. J Clin Psychiatry 2000; 61: 37-41.

    OpenUrlPubMedWeb of Science
19. 19.↵
    1. Pae CU,
    2. Tharwani H,
    3. Marks DM,
    4. Masand PS,
    5. Patkar AA.

    Atypical depression: a comprehensive review. CNS Drugs 2009; 23: 1023-1037.

    OpenUrlCrossRefPubMed
20. 20.↵
    Psychiatric times. (2017) An update on melancholia [online] [Accessed on 20th April2020]. Retrieved from: https://www.psychiatrictimes.com/cme/update-melancholia/page/0/4
21. 21.↵
    1. Malterud K.

    The art and science of clinical knowledge: evidence beyond measures and numbers. Lancet 2001; 358: 397-400.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Rush AJ,
    2. Prien RF.

    From scientific knowledge to the clinical practice of psychopharmacology: can the gap be bridged? Psychopharmacol Bull 1995; 31: 7-20.

    OpenUrlPubMedWeb of Science